Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse Reactions
{{output}}
Biosimilar drugs, close copies of patented biologicals, are intended to provide access to less expensive, highly similar versions of reference (previously approved) biological agents (Kozlowski et al. in N Engl J Med 365:385-388, 2011). The biological epoetin ... ...
